Connection

James Ballenger to Phobic Disorders

This is a "connection" page, showing publications James Ballenger has written about Phobic Disorders.
Connection Strength

1.616
  1. Recognizing the patient with social anxiety disorder. Int Clin Psychopharmacol. 2000 Jul; 15 Suppl 1:S1-5.
    View in: PubMed
    Score: 0.156
  2. Sleep Deprivation in social phobia and generalized anxiety disorder. Biol Psychiatry. 1998 Jun 01; 43(11):840-2.
    View in: PubMed
    Score: 0.135
  3. Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998; 59 Suppl 17:54-60.
    View in: PubMed
    Score: 0.131
  4. Sertraline in social phobia. J Clin Psychopharmacol. 1995 Oct; 15(5):372-3.
    View in: PubMed
    Score: 0.112
  5. Plasma and CSF HVA levels in panic patients with comorbid social phobia. Biol Psychiatry. 1994 Sep 15; 36(6):425-7.
    View in: PubMed
    Score: 0.104
  6. Treatment of social phobia with bupropion. J Clin Psychopharmacol. 1991 Aug; 11(4):276-7.
    View in: PubMed
    Score: 0.084
  7. Panic and phobic disorders in patients with obsessive compulsive disorder. J Clin Psychiatry. 1990 Nov; 51(11):456-8.
    View in: PubMed
    Score: 0.080
  8. Three cases of panic disorder with agoraphobia in children. Am J Psychiatry. 1989 Jul; 146(7):922-4.
    View in: PubMed
    Score: 0.073
  9. Possible relationship of bowel obsessions to panic disorder with agoraphobia. Am J Psychiatry. 1988 Oct; 145(10):1324-5.
    View in: PubMed
    Score: 0.069
  10. Alprazolam in the treatment of social phobia. J Clin Psychiatry. 1988 Jan; 49(1):17-9.
    View in: PubMed
    Score: 0.066
  11. Unrecognized prevalence of panic disorder in primary care, internal medicine and cardiology. Am J Cardiol. 1987 Dec 28; 60(18):39J-47J.
    View in: PubMed
    Score: 0.066
  12. Antidepressants in panic disorder and agoraphobia. J Affect Disord. 1987 Sep-Oct; 13(2):153-68.
    View in: PubMed
    Score: 0.064
  13. Neural correlates of speech anticipatory anxiety in generalized social phobia. Neuroreport. 2004 Dec 22; 15(18):2701-5.
    View in: PubMed
    Score: 0.053
  14. Remission rates in patients with anxiety disorders treated with paroxetine. J Clin Psychiatry. 2004 Dec; 65(12):1696-707.
    View in: PubMed
    Score: 0.053
  15. Treatment of anxiety disorders to remission. J Clin Psychiatry. 2001; 62 Suppl 12:5-9.
    View in: PubMed
    Score: 0.040
  16. Bupropion-SR in treatment of social phobia. Depress Anxiety. 2000; 12(2):111-3.
    View in: PubMed
    Score: 0.038
  17. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry. 1999; 60 Suppl 22:29-34.
    View in: PubMed
    Score: 0.035
  18. Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry. 1995 Nov; 152(11):1665-7.
    View in: PubMed
    Score: 0.028
  19. Comorbidity of axis I psychiatric disorders in bulimia nervosa. J Clin Psychiatry. 1995 Feb; 56(2):77-80.
    View in: PubMed
    Score: 0.027
  20. Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry. 1993 Aug; 150(8):1216-8.
    View in: PubMed
    Score: 0.024
  21. Examining criteria for panic disorder. Hosp Community Psychiatry. 1993 Mar; 44(3):226-8.
    View in: PubMed
    Score: 0.023
  22. Eating disorders and social phobia. Arch Gen Psychiatry. 1993 Jan; 50(1):70.
    View in: PubMed
    Score: 0.023
  23. CSF prostaglandin-E in agoraphobia with panic attacks. Biol Psychiatry. 1989 Jul; 26(3):257-64.
    View in: PubMed
    Score: 0.018
  24. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. J Affect Disord. 1989 Jan-Feb; 16(1):49-58.
    View in: PubMed
    Score: 0.018
  25. Recent advances in the psychopharmacological treatment of anxiety disorders. Hosp Community Psychiatry. 1988 Nov; 39(11):1157-65.
    View in: PubMed
    Score: 0.017
  26. Different rates of improvement of different symptoms in combined pharmacological and behavioral treatment of agoraphobia. J Behav Ther Exp Psychiatry. 1988 Jun; 19(2):119-26.
    View in: PubMed
    Score: 0.017
  27. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Arch Gen Psychiatry. 1988 May; 45(5):423-8.
    View in: PubMed
    Score: 0.017
  28. The dexamethasone suppression test in agoraphobia. J Clin Psychopharmacol. 1985 Apr; 5(2):100-2.
    View in: PubMed
    Score: 0.014
  29. Psychopharmacology of the anxiety disorders. Psychiatr Clin North Am. 1984 Dec; 7(4):757-71.
    View in: PubMed
    Score: 0.013
  30. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry. 1980 Jan; 37(1):51-9.
    View in: PubMed
    Score: 0.009
  31. Infrequent panic attacks: psychiatric comorbidity, personality characteristics and functional disability. J Psychiatr Res. 1995 Mar-Apr; 29(2):121-31.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.